Bar, N., Bahlis, N. J., Lin, Z., Hsu, K., Katz, J., Godwin, C., Costa, L. (2025). Trial in progress: A phase 1b/2a study to evaluate mezigdomide in combination with elranatamab in patients with relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-8246